Edwards Lifesciences Corporation (EW) Balance Sheet

The $3.2B increase in equity over ten quarters, as shown in the data, reflects robust retained earnings and the $4.2B divestiture proceeds, which likely boosted cash and reduced liabilities. This trajectory suggests the balance sheet is not only stable but expanding, providing ample capacity for continued R&D investment and potential M&A in structural heart.

With debt consistently near $700M and equity above $10B, the leverage ratio is exceptionally low, even compared to peers like MDT (0.56) and ABT (0.29). This suggests that the company is not reliant on debt financing, and the modest debt level likely represents operational leases or minor borrowings, posing minimal refinancing risk. The fortress balance sheet supports the high-risk TMTT investment phase.

The relatively stable PPE and goodwill levels suggest that growth is not asset-heavy, but rather driven by R&D and commercial execution. Goodwill of $1.8B, largely from the 2024 acquisition, represents a modest 13.5% of total assets, reducing impairment risk. The asset mix supports the high-margin, IP-centric business model, though investors should monitor goodwill for any future write-downs if TMTT underperforms.

The consistent rise in retained earnings, despite share repurchases totaling $1.9B over the period, indicates that the company is generating substantial profits and reinvesting them effectively. The equity quality is high, with no signs of aggressive buybacks or excessive SBC dilution, as SBC averaged only $42.5M quarterly. This suggests that the equity base is solid and supports the company's ability to fund future innovation.

The current ratio, consistently above 3.4, indicates a highly liquid position, far exceeding the 2.13 of MDT and 1.58 of ABT. Cash of $2.4B, combined with the $4.2B divestiture proceeds, offers substantial runway for R&D and potential acquisitions. This liquidity cushion is critical as the company invests heavily in the TMTT segment, which may require upfront costs before generating returns.